Back to results
US 2003/0125330 A1Published application
4 - (2-butylamino) - 2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-yl) pyrazolo- [1,5-A] - 1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
OwnerPaul J. Gilliganinventor
Life of this patent
Estimating the term…
Abstract
Corticotropin releasing factor (CRF) antagonists of Formula (I): 1 and its use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
Claims17
A compound of Formula (I):
- 4
- isomers thereof, stereoisomeric forms thereof, or mixtures of stereoisomeric forms thereof, pharmaceutically acceptable prodrugs thereof, or pharmaceutically acceptable salt forms.
Dependencies are inferred from the claim text.